slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 64,141-64,170
Pages 2,605
Rows per page 30
Component
64,141-64,170 of 78,138
06
The chart compares 2022 and 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
07
The chart shows a year-over-year comparison of container volume by quarter, with a specific note on the discontinuation of the CCX service.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
08
The chart shows quarterly container volume (FEU) for 2022 and 2023. The 1.9% decrease refers to the 3Q23 vs 3Q22 comparison.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
09
The chart shows a comparison of 2022 vs 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
10
The chart shows a year-over-year comparison of quarterly operating income, with Q3 2023 highlighted as an estimate.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
11
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
The chart illustrates the reconciliation of cash flow from operations to the net change in cash.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
04
The slide uses a dual-track timeline showing the progression of Cell Therapy and Drug Discovery business segments alongside corporate milestones.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
06
The chart shows a cumulative growth of partnerships over time from 2017 to 2023.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Traction1 hit
07
Includes a mix of historical data, pipeline metrics, and future projections.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The chart uses a timeline-based progression from early clinical to commercial phase.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
13
The chart uses a stacked bar format to distinguish between pre-commercial and commercial revenue components.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
08
The chart illustrates the reconciliation of deposit balances between two quarters.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
10
The chart highlights NYCB's consistently lower non-performing loan ratios compared to the industry benchmark.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
11
NYCB is highlighted in gold; peer median is represented by a dashed line.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
12
The chart uses a grouped bar format to contrast two data series over time. Includes a cumulative total box and a footnote regarding specific exclusions.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
16
The slide highlights the bank's focus on multi-family loans and its historical low loss rates.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Executive SummaryLoop · Golden Circle1 hit
17
The slide combines a bar chart showing portfolio size with a table of origination and charge-off data, alongside a summary of portfolio characteristics.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Executive SummaryLoop · Golden Circle1 hit
21
Includes a table of NBV values and a corresponding pie chart for industry distribution.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations 1 hit
06
The slide uses a consistent three-column layout to compare key performance metrics across three distinct game titles.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
13
The background includes a shaded area representing 'Indicative revenue dynamic'.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations Loop · Why Now1 hit
19
The chart displays dose-dependent exposure over 24 hours, with horizontal dashed lines representing efficacy targets for different ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
21
Clinical trial data visualization (waterfall plot) with patient-level characteristics table below.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
22
Swimmer plot showing patient-level treatment duration, response status, and ongoing treatment status.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
38
The chart demonstrates dose-proportional exposure and confirms that doses >= 50 mg QD exceed efficacy thresholds for various ALK mutations in the CNS.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
39
The chart displays patient-level data categorized by dose (15mg to 200mg) and mutation type, highlighting the efficacy of the drug in clearing specific ALK mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
41
Clinical trial data visualization showing ORR and best percentage change in target lesions.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
42
The chart is a swimmer plot, a standard visualization in oncology clinical trials to show time-to-event data for individual patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
44
Includes clinical data points for EML4-ALK v3, G1202R, G1269A, and I1322M.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
50
The slide uses a Gantt-style visualization to represent clinical trial progress.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit